Tendon defects require multimodal therapeutic management over extensive periods and incur high collateral burden with frequent functional losses. Specific cell therapies have recently been developed in parallel to surgical techniques for managing acute and degenerative tendon tissue affections. to optimally stimulate resurgence of structure and function. Cultured primary human fetal p... https://www.jmannino.com/